Cosmos Pharmaceutical Stock Debt To Equity
COSMOS Pharmaceutical fundamentals help investors to digest information that contributes to COSMOS Pharmaceutical's financial success or failures. It also enables traders to predict the movement of COSMOS Pink Sheet. The fundamental analysis module provides a way to measure COSMOS Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COSMOS Pharmaceutical pink sheet.
COSMOS |
COSMOS Pharmaceutical Company Debt To Equity Analysis
COSMOS Pharmaceutical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, COSMOS Pharmaceutical has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
COSMOS Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COSMOS Pharmaceutical's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of COSMOS Pharmaceutical could also be used in its relative valuation, which is a method of valuing COSMOS Pharmaceutical by comparing valuation metrics of similar companies.COSMOS Pharmaceutical is currently under evaluation in debt to equity category among its peers.
COSMOS Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0521 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.89 B | |||
| Shares Outstanding | 39.6 M | |||
| Shares Owned By Insiders | 51.47 % | |||
| Shares Owned By Institutions | 20.75 % | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 755.41 B | |||
| Gross Profit | 151.45 B | |||
| EBITDA | 48.21 B | |||
| Net Income | 23.16 B | |||
| Total Debt | 3 B | |||
| Book Value Per Share | 5,056 X | |||
| Cash Flow From Operations | 32.19 B | |||
| Earnings Per Share | 4.54 X | |||
| Number Of Employees | 5.1 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.89 B | |||
| Total Asset | 363.05 B | |||
| Z Score | 2.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 363.05 B | |||
| Last Dividend Paid | 40.0 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |